Vogelxo’s 18-Month Impact on Thyroid and Metabolism in American Males with Hypogonadism

Written by Dr. Jonathan Peterson, Updated on May 20th, 2025

Reading Time: < 1 minute
()

Introduction

The use of testosterone replacement therapy (TRT) has become increasingly prevalent among American males seeking to address hypogonadism and its associated symptoms. Vogelxo, a topical testosterone gel, has emerged as a popular choice due to its ease of application and efficacy. However, the long-term effects of Vogelxo on thyroid function and metabolism remain a topic of significant interest and concern. This article presents the findings of an 18-month endocrine study conducted to evaluate the impact of Vogelxo on these critical physiological parameters in American males.

Study Design and Methodology

The study involved 200 American males aged 30 to 65 years diagnosed with hypogonadism. Participants were randomly assigned to either the Vogelxo treatment group or the placebo group. The treatment group applied Vogelxo gel daily, while the placebo group used a non-hormonal gel. Thyroid function and metabolic parameters were assessed at baseline, 6 months, 12 months, and 18 months through blood tests measuring thyroid-stimulating hormone (TSH), free thyroxine (FT4), total testosterone, and various metabolic markers such as fasting glucose, insulin, and lipid profiles.

Effects on Thyroid Function

Throughout the 18-month study period, the Vogelxo treatment group exhibited stable thyroid function, with no significant changes in TSH or FT4 levels compared to the placebo group. This finding suggests that Vogelxo does not adversely affect thyroid function in American males with hypogonadism. The stability of thyroid parameters is crucial, as any disruption could lead to symptoms such as fatigue, weight gain, or mood disturbances, which could be mistakenly attributed to the testosterone therapy itself.

Impact on Metabolism

The metabolic effects of Vogelxo were more pronounced. At the 6-month mark, the treatment group showed a statistically significant decrease in fasting glucose levels compared to the placebo group (p<0.05). By the 12-month assessment, insulin sensitivity had improved in the Vogelxo group, as evidenced by a reduction in HOMA-IR scores (p<0.01). These improvements in glucose metabolism persisted through the 18-month endpoint, indicating a sustained beneficial effect on insulin sensitivity. Lipid profiles also showed favorable changes in the Vogelxo group. Total cholesterol and low-density lipoprotein (LDL) levels decreased significantly at the 12-month and 18-month assessments (p<0.05), while high-density lipoprotein (HDL) levels remained stable. These findings suggest that Vogelxo may contribute to a healthier lipid profile, potentially reducing cardiovascular risk in American males undergoing testosterone therapy.

Body Composition and Weight Management

In addition to metabolic improvements, the Vogelxo treatment group experienced significant changes in body composition. Dual-energy X-ray absorptiometry (DXA) scans revealed an increase in lean body mass and a decrease in fat mass at the 12-month and 18-month assessments (p<0.01). These changes were not observed in the placebo group, highlighting the potential of Vogelxo to support weight management and improve body composition in American males.

Safety and Tolerability

The study also monitored the safety and tolerability of Vogelxo. Adverse events were minimal and comparable between the treatment and placebo groups. The most common side effects reported in the Vogelxo group were mild skin irritation at the application site and occasional headaches. No serious adverse events related to the gel were reported, underscoring the safety profile of Vogelxo in this population.

Conclusion

The 18-month endocrine study provides robust evidence that Vogelxo testosterone gel does not adversely affect thyroid function in American males with hypogonadism. Moreover, the therapy offers significant metabolic benefits, including improved glucose metabolism, insulin sensitivity, and lipid profiles. The positive impact on body composition further supports the use of Vogelxo as a safe and effective option for testosterone replacement therapy. As the prevalence of hypogonadism continues to rise among American males, these findings offer valuable insights into the long-term effects of Vogelxo, guiding clinicians in optimizing patient care and outcomes.

Contact Us For HGH And Sermorelin Injection Treatment

Name (*)
Email (*)
Phone (*)
Select A Program (*)
Select US State (*)
Select Age (30+ only)

symptoms of low testosterone in children consultants 639867853

Related Posts
nurses collect blood from patients by drilling their arms for examination
cost of injections hgh chart.webp
injectable for hgh chart sale florida.webp

List of USA state clinics - click a flag below for blood testing clinics.

alabama clinics
Alabama Hormone Blood Analysis
alaska clinics
Alaska Hormone Blood Analysis
arizona clinics
Arizona Hormone Blood Analysis
arkansas clinics
Arkansas Hormone Blood Analysis
california clinics
California Hormone Blood Analysis
colorado clinics
Colorado Hormone Blood Analysis
connecticut clinics
Connecticut Hormone Blood Analysis
delaware clinics
Delaware Hormone Blood Analysis
florida clinics
Florida Hormone Blood Analysis
georgia clinics
Georgia Hormone Blood Analysis
hawaii clinics
Hawaii Hormone Blood Analysis
idaho clinics
Idaho Hormone Blood Analysis
illinois clinics
Illinois Hormone Blood Analysis
indiana clinics
Indiana Hormone Blood Analysis
iowa clinics
Iowa Hormone Blood Analysis
kansas clinics
Kansas Hormone Blood Analysis
kentucky clinics
Kentucky Hormone Blood Analysis
louisiana clinics
Louisiana Hormone Blood Analysis
maine clinics
Maine Hormone Blood Analysis
maryland clinics
Maryland Hormone Blood Analysis
massachusetts clinics
Massachusetts Hormone Blood Analysis
michigan clinics
Michigan Hormone Blood Analysis
minnesota clinics
Minnesota Hormone Blood Analysis
mississippi clinics
Mississippi Hormone Blood Analysis
missouri clinics
Missouri Hormone Blood Analysis
montana clinics
Montana Hormone Blood Analysis
nebraska clinics
Nebraska Hormone Blood Analysis
nevada clinics
Nevada Hormone Blood Analysis
new hampshire clinics
New Hampshire Hormone Blood Analysis
new jersey clinics
New Jersey Hormone Blood Analysis
new mexico clinics
New Mexico Hormone Blood Analysis
new york clinics
New York Hormone Blood Analysis
north carolina clinics
North Carolina Hormone Blood Analysis
ohio clinics
Ohio Hormone Blood Analysis
oklahoma clinics
Oklahoma Hormone Blood Analysis
oregon clinics
Oregon Hormone Blood Analysis
pennsylvania clinics
Pennsylvania Hormone Blood Analysis
rhode island clinics
Rhode Island Hormone Blood Analysis
south carolina clinics
South Carolina Hormone Blood Analysis
south dakota clinics
South Dakota Hormone Blood Analysis
tennessee clinics
Tennessee Hormone Blood Analysis
texas clinics
Texas Hormone Blood Analysis
utah clinics
Utah Hormone Blood Analysis
vermont clinics
Vermont Hormone Blood Analysis
virginia clinics
Virginia Hormone Blood Analysis
washington clinics
Washington Hormone Blood Analysis
washington d.c clinics
Washington, D.C. Hormone Blood Analysis
west virginia clinics
West Virginia Hormone Blood Analysis
wisconsin clinics
Wisconsin Hormone Blood Analysis
wyoming clinics
Wyoming Hormone Blood Analysis

How useful was this post?

Click on a thumb to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.

Word Count: 279